Proof has a boundary
What does the evidence prove?
A code, a badge and a study can sound reassuring. Ask what each one actually establishes about the proposed care.
Approval, registration and a code are different
Ask: “What does this source show about the medicine being offered?” An entry in an online product list may tell you its name. A licence record may tell you who is allowed to practise. Those records alone do not show whether the proposed care is right for you.
Registration
A company can be registered with the FDA, meaning it is recorded in the agency’s records. A medicine can also appear on its product list. Neither fact means the FDA approved the business or medicine.
NDC
National Drug Code is the full name of NDC. This number identifies a medicine listed in the FDA’s product records.
Having this number does not establish FDA approval for the medicine.
As of September 26, 2026.
FDA: what a drug code meansEvidence for a ready-made medicine has limits
A custom version
Be wary of a claim that a made-to-order medicine was tested in people and works just like the approved product. The FDA says that claim is false or misleading.
As of September 26, 2026.
FDA: claims about custom productsDoes this evidence concern the exact product and the use being proposed to me?
A headline about a committee is not a new rule
Advisory committee
The FDA keeps a list of certain raw ingredients that ordinary pharmacies may use for made-to-order medicines. This is one way an ingredient can qualify. It still needs required quality records and must come from an FDA-registered maker.
A committee advises the FDA about this list, but a vote does not change it. The FDA must invite people’s views and complete a new rule before it changes the list.
As of September 26, 2026.
FDA ingredient rules: how the list changesReports and enforcement letters need context
Problem reports
A problem report by itself cannot prove cause or tell you how often a medicine causes harm.
As of September 17, 2026.
FDA: limits of problem reportsAn enforcement letter
A warning letter from the FDA sets out the concerns the agency had at the time of sending it. Later replies from the company and further FDA review may change the agency’s view of the problem.
The letter states a concern; it is not a final decision that the company broke a rule.
Finding no letter does not mean the FDA cleared a product or business.
As of September 17, 2026.
FDA: letters and their limits